| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |